Apellis Pharmaceuticals, Inc.
2020 Q4 - 2025 Q4 (21 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/28/2026 | 282 | 0.0% | 11,225 | 12/31/2025 |
| 2025 Q3 | 10/30/2025 | 419 | 0.0% | 18,512 | 9/30/2025 |
| 2025 Q2 | 8/1/2025 | 351 | 0.0% | 20,287 | 6/30/2025 |
| 2025 Q1 | 4/28/2025 | 404 | 0.0% | 18,459 | 3/31/2025 |
| 2024 Q4 | 2/11/2025 | 691 | 0.0% | 21,649 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 571 | 0.0% | 19,785 | 9/30/2024 |
| 2024 Q2 | 8/9/2024 | 662 | 0.0% | 17,270 | 6/30/2024 |
| 2024 Q1 | 5/6/2024 | 930 | 0.0% | 15,823 | 3/31/2024 |
| 2023 Q4 | 2/7/2024 | 1,139 | 0.0% | 19,031 | 12/31/2023 |
| 2023 Q3 | 10/31/2023 | 879 | 0.0% | 23,099 | 9/30/2023 |
| 2023 Q2 | 7/19/2023 | 1,995 | 0.0% | 21,896 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 1,797 | 0.0% | 27,251 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 1,396 | 0.0% | 27,002 | 12/31/2022 |
| 2022 Q3 | 11/3/2022 | 1,903 | 0.0% | 27,862 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 555 | 0.0% | 12,265 | 6/30/2022 |
| 2022 Q1 | 5/9/2022 | 803 | 0.0% | 15,795 | 3/31/2022 |
| 2021 Q4 | 2/10/2022 | 692 | 0.0% | 14,636 | 12/31/2021 |
| 2021 Q3 | 11/9/2021 | 315 | 0.0% | 9,551 | 9/30/2021 |
| 2021 Q2 | 8/5/2021 | 464 | 0.0% | 7,344 | 6/30/2021 |
| 2021 Q1 | 5/11/2021 | 267 | 0.0% | 6,232 | 3/31/2021 |
| 2020 Q4 | 2/11/2021 | 289 | 0.0% | 5,059 | 12/31/2020 |